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Abstract
Background: Reports on the effect of age and obesity on myocardial ischaemia/reperfusion (I/R) injury and
ischaemic preconditioning are contradictory. The aim of this study was to re-evaluate the effects of age and
diet-induced obesity (DIO) on myocardial I/R injury and preconditioning potential.
Methods: Four groups of Wistar male rats were used: age-matched controls (AMC) receiving standard rat chow
for (i) 16 weeks and (ii) 16 months respectively; DIO rats receiving a sucrose-supplemented diet for (iii)
16 weeks and (iv) 16 months respectively. The ages of groups (i) and (iii) were 22 weeks (“young”) and groups
(ii) and (iv) 17 months (“middle-aged”) at time of experimentation. Isolated perfused working hearts were
subjected to 35 min regional ischaemia/1 h reperfusion. Endpoints were infarct size (tetrazolium staining) and
functional recovery. Hearts were preconditioned by 3 × 5 min ischaemia/5 min reperfusion. Results were
processed using GraphPad Prism statistical software.
Results: Age did not affect baseline heart function before induction of ischaemia and I/R damage as indicated
by infarct size and similar values were obtained in hearts from both age groups. Age also had no effect on
functional recovery of hearts during reperfusion after regional ischaemia in AMC rats, but cardiac output during
reperfusion was better in hearts from middle-aged than young DIO rats.
The diet reduced infarct size in hearts from young rats (% of area at risk: AMC: 32.4 ± 3.6; DIO: 20.7 ± 2.9, p < 0.05), with
no differences in hearts from middle-aged rats (AMC: 24.6 ± 4.6; DIO: 28.3 ± 13.5, p = NS). Compared to their respective
AMC, diet-induced obesity had no significant effect on functional recovery of hearts from both age groups after
exposure to regional ischaemia.
When exposed to the more severe stress of global ischaemia, the functional recovery potential of middle-aged
DIO rats appeared to be impeded compared to hearts of young DIO rats, while age had no effect on the
functional recovery of AMC hearts.
Preconditioning reduced infarct size in hearts from young control rats and both middle-aged groups, but not
from young DIO rats. Age had a significant effect on functional recovery in preconditioning: it was improved in
hearts from young control and DIO rats, but depressed in both middle-aged groups.
Conclusions: The data showed that middle-age and obesity had no effect on baseline myocardial function and
did not increase susceptibility to I/R damage upon exposure to regional ischaemia. On the contrary, obesity
reduced I/R damage in young rats. Preconditioned aging hearts showed a decreased infarct size, but a reduction
in functional recovery.
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Background
The effect of ischaemia/reperfusion (I/R) on the myocar-
dium as well as its response to cardioprotective inter-
ventions are influenced by several variables, amongst
others, age and obesity. The respective contributions of
the latter two factors have recently been extensively
reviewed [1–4].
It is of significance that the vast majority of studies
on the response of the heart to I/R injury, the processes
involved and the consequences of interventions, have
been conducted on healthy or mature populations of
experimental animals. As cardiovascular diseases are
the leading cause of death, particularly in the elderly,
cognizance should be taken of the role of age-induced
changes in the response of the heart to pathophysio-
logical conditions. The effects of increasing age on the
cardiovascular system are well-established and entail,
amongst others, an increase in left ventricular mass, myo-
cyte hypertrophy and a reduction in myocyte number
[5–7]. Apart from the significant changes in β-
adrenergic signalling [8, 9], mitochondrial ROS pro-
duction also increases with age, which in turn, may
cause mitochondrial damage [6]. The amounts of ROS
generated are critical for the fate of the cell, since low
amounts can function as signalling molecules and are
important in cardioprotection, whereas high amounts
are detrimental by opening the mitochondrial perme-
ability transition pore, causing cell death [10].
Aging decreases the intrinsic tolerance of the heart to
ischaemic injury. For example, it has been shown that
loss of myocardial tolerance to ischaemia in the mouse
begins during the middle-age (~12 months) and be-
comes outspoken at 18–24 months of age [11]. This in-
creased susceptibility of the heart to I/R damage is
likely to be the consequence of enhanced oxidative
stress [11–13].
In addition to the effects of old age on the response of
the heart to I/R, obesity is also considered to be a ser-
ious risk factor in the development of cardiovascular
disorders and is regarded to impact negatively on the
outcome of myocardial ischaemia. Since obesity associ-
ated with insulin resistance has been demonstrated to
increase oxidative stress, and is associated with coronary
artery disease [14–16], I/R occurring in this condition
could provoke a further increase in oxidative stress.
However experimental studies reported a variety of out-
comes. A decreased myocardial tolerance to I/R damage
was observed in vivo [17] and ex vivo studies using
hyperphagia-induced obese insulin resistant male Wistar
rats [18–21]. These studies have shown that an increased
infarct size is associated with concomitant poor func-
tional recovery in hearts from obese rats compared with
controls. In contrast to the above, smaller infarcts and
an improved functional recovery during reperfusion
were reported by Donner and coworkers [22] also using
a hyperphagia-induced obesity rat model. A recent study
from our own laboratory also showed that hearts from
rats fed either a sucrose-supplemented diet or a high
fat diet for 16 weeks presented with a significant reduc-
tion in infarct size when subjected to 35 min regional
ischaemia/60 min reperfusion, when compared to age-
matched controls [23]. Furthermore, the degree of left
ventricular (LV) dysfunction in Zucker obese rats dur-
ing I/R was reported to be similar to that of lean rats
[24]. At the moment the reason(s) for these discrepan-
cies are not clear and could be another manifestation of
the phenomenon of the “obesity-paradox” which has
been observed in humans: Observational studies have
shown that obese heart failure patients tend to have
higher survival rates compared to patients with heart
failure and normal BMI values [25, 26].
In agreement with the marked effects of age on the
susceptibility of the heart to I/R damage, a number of
experimental studies showed that the cardioprotective
power of ischaemic pre- and postconditioning waned
with ageing (for reviews see [1–3]), despite variations in
age and preconditioning protocols. The majority of
these studies used haemodynamic recovery as endpoint
[27–30], with only a few employing the more robust
endpoint of infarct size [31, 32]. . It should be borne in
mind that in these ex vivo studies, using the isolated
perfused heart, the period of ischaemia was followed by
immediate reperfusion, usually for 60 min, during
which time functional recovery was determined. This
protocol therefore does not allow evaluation of chronic
recovery. Clearly the effects of age and obesity should
also be evaluated in an in vivo model which allows
study of the consequences of I/R on chronic recovery.
In view of earlier observations made in our laboratory,
namely that hearts from rats with hyperphagia-induced
insulin-resistance, aged 22 weeks, are characterized by an
unaltered functional performance and an improvement in
resistance to I/R injury [23], the aim of the present study
was to re-evaluate the effects of age and obesity-induced
insulin resistance on myocardial susceptibility to I/R dam-
age and functional performance during reperfusion as well
as the capacity to be protected by prior ischaemic precon-
ditioning. For this purpose two age groups were used,
namely 22 weeks and 17 months. The precise correlation
between the age of laboratory rats and the human is still a
matter of debate and complicated by the different phases
of life. It has been estimated that in general, considering
their entire life span, a human month resembles one
every-day life of a laboratory rat [33]. Based on these as-
sumptions, it was calculated that the 22 weeks old and
17 months old rats represent 13 and 43 human years
respectively and were referred to as “young” and “middle-
aged” throughout the article.
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Methods
Animals
Age and weight matched male Wistar rats were used in
this study. This study was approved by the Committee
for Ethical Animal Research of the Faculty of Medicine
and Health Sciences, University of Stellenbosch (ethical
approval number SU-ACUM11-00002). Animals were
treated according to the revised South African National
Standard for the Care and Use of Animals for Scientific
Purposes (South African Bureau of Standards, SANS
10386, 2008). Rats were obtained from the University of
Stellenbosch Central Research Facility. Two to three rats
were housed in one cage. They received water and food
ad libitum (light/dark cycle 6 h00–18 h00; temperature
22 °C; humidity 40%). Rats aged 6 weeks were divided
into four groups: (i) age matched control (AMC) rats re-
ceived a standard commercial rat chow for 16 weeks, (ii)
diet-induced obese rats received a sucrose-supplemented
diet (DIO) for 16 weeks, (iii) age-matched control rats
received standard rat chow for 16 months and (iv) diet-
induced obese rats received the DIO diet for 16 months
The age of groups (i) and (ii) at the time of experimenta-
tion averaged 22 weeks (“young”), while the age of
groups (iii) and (iv) averaged 17 months (middle-aged)
at the time of experimentation. Except in the case of the
echographic studies where four rats per group were
studied, in all other experiments the n values varied be-
tween 6 and 9 rats/group. Based on previous experimen-
tation in our laboratory, these numbers were sufficient
for the purpose of the study [20, 21]. The DIO diet was
prepared by addition of condensed milk and sucrose to
the standard rat chow as described by Pickavance and
coworkers [34]. The composition of the control and
DIO diets was analyzed by Microchem, Cape Town: the
DIO diet contained three and four fold more saturated
fats and sucrose respectively than the control diet while
the total carbohydrate content was 33% higher, as de-
scribed before [23].
Chemicals
Routine chemicals (pro analysi) were obtained from
Merck Chemical Co (Cape Town, RSA).
Experimental procedure
At the end of the feeding period, non-fasted rats were
weighed and anaesthetized with pentobarbital (30 mg/rat).
They were then sacrificed, the hearts removed and
arrested in ice-cold saline for subsequent perfusion in
the working mode. The visceral fat was collected and
weighed.
Perfusion technique
Hearts were perfused as described before [35]. Briefly, a
modified Krebs-Henseleit bicarbonate buffer was used,
containing (in mM): NaCl 119; NaHCO3 24.9; KCl 4.7;
KH2PO4 1.2; MgSO4.7H2O 0.59; Na2SO4 0.59; CaCl2
1.25; glucose 10. The buffer was oxygenated with a
95%oxygen/5%CO2 gas mixture at 37 °C.
All perfused hearts were stabilized by retrograde per-
fusion for 15 min, followed by perfusion for 15 min in
the working mode (preload 15 cm H2O, afterload
100 cm H2O), during which time the aortic and coron-
ary flow rates were measured. Systolic pressure and
heart rate were measured through a side-arm of the aor-
tic cannula connected to a Viggo-Spectramed pressure
transducer coupled to a computer system.
After stabilization, hearts were perfused for 30 min in
the retrograde mode, subjected to 15 min global ischae-
mia or 35 min regional ischaemia (36.5 °C) and 60 min
reperfusion for measurements of functional recovery (at
20 and 30 min reperfusion) and infarct size after 60 min.
The ability to be preconditioned was studied in DIO and
age-matched control rats of both age groups. In these
studies, after the 30 min stabilization period, hearts were
perfused retrogradely for either 30 min (non-precondi-
tioned (NPC)) or for 10 min followed by a precondition-
ing protocol of 3x5min ischaemia/5 min reperfusion,
followed by 35 min regional ischaemia (36.5 °C) and
60 min reperfusion for measurements of functional re-
covery and infarct size.
Determination of infarct size
Myocardial infarct size was determined as described pre-
viously, using tetrazolium staining [36]. Each heart was
cut in 2 mm thick slices. For each slice the left ventricle
area at risk and the infarcted areas were determined
using computerized planimetry (UTHCSA Image Tool
programme, University of Texas Health Science Center
at San Antonio, TX, USA).
Echocardiography
Echocardiography was used to monitor the heart function
and structure in vivo. Cardiac geometry and function were
evaluated in anaesthetized (2.0% Isoflurane) rats using
two-dimensional guided M-mode echocardiography
(Vivid e, GE Healthcare) equipped with a 15–2 MHz
linear transducer. Wall thicknesses and diastolic and
systolic left ventricular dimensions were recorded from
M-mode images acquired through the anterior and pos-
terior LV walls at the papillary muscle level. This was a
blinded study, and all studies were performed and
interpreted by an independent operator.
Statistical analysis
Results were processed using GraphPad Prism statistical
software (versions 5 and 6). All results were expressed as
mean ± standard error of the mean (SEM). For compari-
sons between groups, an analysis of variance (ANOVA),
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followed by the Bonferroni correction was applied. Com-
parison between functional performance before and after
ischaemia during reperfusion, was done by use of Student’s
t test. A p-value of p < 0.05 was considered significant.
The manuscript has been prepared according to the AR-
RIVE guidelines (http://www.nc3rs.org.uk/page.asp?id=1357),
using the ARRIVE Guidelines checklist.
Results
Biometric data (Table 1)
The body mass of rats on the DIO diet was signifi-
cantly higher than those of their age-matched controls
in both young (22 weeks) (30% higher) and middle-aged
(17 months) (23% higher) groups. Similarly in both
groups the intraperitoneal fat was significantly higher in
rats on the DIO diet. However, the % change in the lat-
ter parameter was significantly higher in the young diet
group (131%), than in the middle-aged (44%) rats, when
compared to their respective age-matched controls.
Infarct size
Age did not appear to affect the susceptibility of the
heart to I/R damage: there was no significant difference
in infarct size of hearts from young and middle-aged
age-matched control rats when subjected to the same
period of regional ischaemia (35 min) followed by 1 h
reperfusion. Similarly there were no significant differ-
ences between infarct sizes of hearts from young and
middle-aged DIO rats when exposed to a similar period
of regional ischaemia and reperfusion (Fig. 1).
As was also observed in an earlier study from our la-
boratory [23], the DIO diet for 22 weeks had a signifi-
cant effect on infarct size after 35 min coronary artery
ligation: infarct size was significantly lower in hearts
from young rats when compared with their age-matched
controls (Infarct size, % of area at risk: AMC 32.4 ± 3.6;
DIO 20.7 ± 2.9; p < 0.05). Interestingly, in hearts from
middle-aged rats no differences in infarct size were ob-
served between the control and DIO groups (AMC:
24.6 ± 4.6; DIO 28.3 ± 3.5) (Fig. 1).
The area at risk did not differ between the DIO and
age-matched controls in both age groups (young rats:
AMC: 51.42 ± 1.33; DIO: 53.41 ± 0.87; middle-aged rats:
AMC: 53.28 ± 4.5; DIO: 49.64 ± 5.0).
Functional recovery during reperfusion after 35 min
regional ischaemia
For evaluation of the function of the heart under base-
line conditions and its response to ischaemia and reper-
fusion, use was made of the working rat heart model
which allows measurement of cardiac pump function at
fixed pre- and afterloads [37]. Failure to produce aortic
output during reperfusion, while still capable of generat-
ing pressure (as reflected by the peak systolic pressure
development), has a significant effect on the evaluation
of Total Work performed. We therefore also indicated
the number of hearts able to produce aortic output dur-
ing reperfusion (Tables 2, 3, 4 and 5), as this is also
regarded as an additional indicator of the recovery po-
tential of the heart during reperfusion.
Interestingly, function of the isolated working heart be-
fore induction of ischaemia, was not affected by age and
similar values were obtained in hearts from young and
middle-aged age-matched control as well as DIO rats.
At both ages studied, in all four groups, functional re-
covery during reperfusion, was significantly lower than
that observed during the stabilization phase before in-
duction of ischaemia, with only a few exceptions namely
unchanged heart rates in hearts from young and middle-
aged DIO rats as well as in hearts from middle-aged
controls, while coronary flow rates during reperfusion of
middle-aged control and DIO hearts were also unaltered
(see Table 2).
However, although the changes were of borderline
significance, middle-aged control hearts appeared to re-
cover better during reperfusion (5/8) than hearts from
their young counterparts (3/6). In particular, while cor-
onary flow during reperfusion was significantly lower in
hearts from young rats (62% reduction), no change in
this parameter was observed in hearts from middle-aged
Table 1 Biometric data: effects of age and diet
Body weight (g) Intraperitoneal fat (g)
22 weeks
Age-matched controls (22) 362 ± 8.8 10.7 ± 0.9
DIO (30) 469 ± 7.9* 24.7 ± 1.0*
17 months
Age-matched controls (21) 682 ± 16 64.4 ± 3.5
DIO (23) 836 ± 51* 93 ± 5.8*
Values in brackets indicate number of animals
* p < 0.05 vs Age-matched controls
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Fig. 1 Effect of age and diet on infarct size (% of area at risk). n = 6/
group. Abbreviations: AMC: age-matched controls: DIO: diet-induced
obese rats; MA: middle-aged
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rats. This improved performance was also reflected by
the higher percentage recovery in Total Work performed
(young: 19.7 ± 9.4 vs middle-aged: 42.4 ± 9.2).
In hearts from DIO rats, age had less effect on func-
tional recovery despite the lower coronary flow rate dur-
ing reperfusion of hearts from young rats, compared to
no change in the middle-aged group. The percentage re-
covery in Total Work performed averaged 34.8 ± 2.99%
in young hearts compared to 41.8 ± 6.6% in hearts from
middle-aged animals, while 6/6 and 8/9 hearts were able
to produce aortic output during reperfusion in the
young and middle-aged DIO groups respectively.
The diet had very little effect on functional recovery.
In the case of hearts from the young group, all parame-
ters during reperfusion (except heart rate) were similar
in hearts from age-matched controls and DIO rats. In
addition, the percentage recovery in the Total Work did
not differ significantly between the groups (age-matched
control hearts 19.7 ± 9.4%, vs DIO 34.8 ± 3.0%, p NS).
However, it does appear that at this age, hearts from the
DIO group were able to withstand a period of ischaemia
better than their control age-matched counterparts since
all these hearts were able to produce aortic output (6/6),
compared to 3/6 in the control group.
In the case of the middle-aged rats, the diet was also
without effect on functional recovery and similar values
were obtained in hearts from control and DIO rats dur-
ing reperfusion. The percentage recovery in Total Work
averaged 42.4 ± 9.2% and 41.8 ± 6.6% in hearts from con-
trol and DIO rats respectively.
Functional recovery of hearts subjected to 15 min global
ischaemia
To further evaluate the effect of age and diet on the sus-
ceptibility of the heart to I/R damage, hearts from young
and middle-aged rats were subjected to a more severe
stress namely 15 min global ischaemia and functional re-
covery during reperfusion determined (Table 3). As was
observed after regional ischaemia, exposure of hearts
from young control and DIO rats to 15 min global is-
chaemia caused a highly significant reduction in aortic
output, cardiac output, PSP and Total Work. This re-
duction in functional performance was much less in
both control and DIO hearts at 17 months of age.
Table 2 Effect of age and diet on functional recovery during reperfusion after 35 min regional ischaemia
Coronary flow
(ml/min)
Aortic flow
(ml/min)
Cardiac output
(ml/min)
Heart rate
(beats/min)
PSP
(mm Hg)
Total Work
(mW)
Total work
(% recovery)
Age 22 weeks
Age-matched controls (6)
a3/6 Before 18.3 ± 0.6 39.7 ± 3.5 57.7 ± 3.8 259 ± 6 92 ± 2 11.86 ± 1.01
After 6.9 ± 3.1 8.7 ± 4.1 15.6 ± 7.1 127 ± 57 42 ± 19 2.64 ± 1.23 19.7 ± 9.4
p 0.0051 0.0002 0.0004 0.0422 0.0226 0.0002
DIO (6)
a6/6 Before 17.3 ± 0.7 33.7 ± 0.8 51.0 ± 0.9 243 ± 8 92 ± 1 10.48 ± 0.32
After 10.4 ± 1.0 9.2 ± 1.6 19.5 ± 1.7 246 ± 9 84 ± 1.9 3.67 ± 0.38 34.8 ± 2.99b
P 0.0002 0.0001 0.0001 NS 0.0134 0.0001
Age 17 months
Age-matched controls (8)
a5/8 Before 20.5 ± 1.5 45.0 ± 1.4 65.5 ± 2.0 235 ± 11 104 ± 1 15.02 ± 0.50
After 22.1 ± 2.4 13.6 ± 4.9 35.8 ± 6.3 236 ± 37 77 ± 11 6.58 ± 1.58 42.4 ± 9.2
p NS 0.0001 0.0005 NS 0.0409 0.0003
p1 0.0021 NS NS NS NS NS NS
DIO (9)
a7/9 Before 19.0 ± 21 37.6 ± 3.4 56.6 ± 4.0 253 ± 17 100 ± 3 12.62 ± 1.12
After 22.3 ± 2.6 7.2 ± 1.8 29.6 ± 3.2 211 ± 34 77 ± 10 5.24 ± 0.86 41.76 ± 6.6b
p NS 0.0001 0.0003 NS 0.0375 0.0005
p2 0.0037 NS 0.0309 NS NS NS NS
p values indicate significance of difference between “after” and “before” values in each group
p1 indicate significance of difference between “after” values of young and middle- aged matched controls
p2 values indicate significance of difference between “after” values of young and middle-aged DIO
Numbers in brackets indicate number of rats
a Indicates number of hearts able to produce aortic output during reperfusion
b % recovery in Total work did not differ significantly from age-matched control
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Although recovery of hearts from young and middle-
aged control hearts was similar, the data obtained sug-
gest that hearts from middle-aged DIO rats were more
susceptible to severe ischaemia: although the percentage
recovery in Total Work during reperfusion of the older
groups did not differ significantly (control 66.8 ± 16.7%
vs DIO 43.6 ± 20.11%, p > 0.05), 5/6 of the control hearts
produced aortic output during reperfusion, compared to
3/6 in the diet group. In addition, the heart rate and PSP
of the latter group were significantly lower than those of
their younger DIO counterparts.
Effect of age and diet on ischaemic preconditioning
potential
As previously reported from our laboratory [23], hearts
from young control rats can be preconditioned effect-
ively by exposure to a preconditioning protocol of 3 × 5
min ischaemia/reperfusion: this resulted in a highly sig-
nificant reduction in infarct size (P < 0.002). At this age
infarct size of NPC DIO hearts was significantly lower
than those of NPC hearts from age-matched controls
(p < 0.02). These hearts could not be further protected
against ischaemic damage by prior preconditioning and
infarct size was similar to those of NPC DIO hearts
(Fig. 2).
After 17 months on the diet, the pattern changed
(Fig. 3): at this age, hearts from control rats as well as
hearts from DIO rats could be effectively preconditioned
causing a significant reduction in infarct size in both
groups.
The areas at risk for hearts from age matched control
and DIO rats (NPC as well as preconditioned) did not
differ (results not shown).
Ischaemic preconditioning and functional recovery during
reperfusion
As previously observed (Table 2), no significant differ-
ence was observed in the baseline function before the
onset of ischaemia of NPC as well as PC hearts from
young control age-matched and DIO rats (see Table 4).
In the NPC hearts from both control and DIO groups,
exposure to 35 min regional ischaemia caused a
Table 3 Effect of age and diet on functional recovery during reperfusion after 15 min global ischaemia
Coronary flow
(ml/min)
Aortic flow
(ml/min)
Cardiac output
(ml/min)
Heart rate
(beats/min)
PSP
(mm Hg)
Total Work
(mW)
Total work
(% recovery)
22 Weeks
Age-Matched Controls (6)
a6/6 Before 18.5 ± 0.9 46.1 ± 1.7 64.6 ± 2.2 282 ± 9 100 ± 2 14.40 ± 0.50
After 15.5 ± 1.4 23.1 ± 3.2 38.7 ± 4.1 277 ± 9 90 ± 2 7.81 ± 0.90 53.1 ± 4.8
p NS 0.005 0.0001 NS 0.0001 0.0001
DIO (6)
a6/6 Before 19.1 ± 1.2 43.2 ± 1.3 62.3 ± 2.1 285 ± 9 99 ± 1 13.80 ± 0.47 69.4 ± 3.0+
After 17.7 ± 0.8 28.4 ± 1.2 46.1 ± 1.5 272 ± 7 91 ± 1 9.38 ± 0.40
p NS 0.0001 0.0001 NS 0.001 0.0001
p1 NS NS NS NS NS NS
17 months
Age-matched controls (6)
a5/6 Before 19.0 ± 3 48.0 ± 3.0 67.0 ± 3.6 274 ± 11 101 ± 2 14.91 ± 0.9
After 19.0 ± 1 29.7 ± 8.1 48.7 ± 8.7 223 ± 47 80 ± 16 9.72 ± 2.47 66.8 ± 16.7
p NS 0.041 NS NS NS NS
p2 NS NS NS NS NS NS NS
DIO (6)
a3/6 Before 21.7 ± 1.7 36.3 ± 6.5 58.0 ± 6.5 258 ± 8 99 ± 2.5 12.84 ± 1.71
After 21.3 ± 1.7 18.0 ± 9.3 39.3 ± 9.4 107 ± 53 47 ± 21 6.21 ± 3.0 43.6 ± 20.1
p NS NS NS 0.026 NS NS NS
p1 NS NS NS 0.05 NS NS NS
p3 0.049 NS NS 0.001 0.0172 NS NS
p values indicate significance of difference between “before” and “after” values in each group; p1 values indicate significance of difference between “after” values
of age-matched controls and DIO at 22 weeks and 17 months respectively; p2 values indicate significance of difference between “after” values of controls at
22 weeks and 17 months; p3 values indicate significance of difference between “after” values of DIO at 22 weeks and 17 months. a Number of hearts which
produced aortic output during reperfusion. Number in brackets indicate number of rats. + p = 0.0086 vs 22 weeks age-matched controls
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significant reduction in coronary flow, aortic flow, car-
diac output, PSP and total work during reperfusion,
compared to values obtained before induction of
ischaemia.
Ischaemic preconditioning caused a significant im-
provement in several parameters of function during
reperfusion in hearts from young control rats
(Table 4). This was particularly evident in the case
of coronary flow, aortic flow, cardiac output and
Total Work performed during reperfusion. For ex-
ample, preconditioning increased the percentage re-
covery in Total Work from 19.7 ± 9.4 to 60.8 ± 4.5
(p = 0.0051) in these hearts. This improvement in
post-ischaemic outcome was also seen in the fact
that all (5/5) preconditioned hearts produced aortic
output during reperfusion, compared to 3/6 in the
non-preconditioned series.
However, in the case of hearts from young DIO rats,
preconditioning did not cause a significant increase in
functional performance during reperfusion and similar
values were obtained as in the non-preconditioned
hearts (Table 4).
The effect of diet on the preconditioning potential of
hearts from middle-aged rats is summarized in Table 5.
As observed previously, baseline functional performance
did not differ significantly between the two DIO groups,
but was significantly lower in the preconditioned age
-matched control group than that of the corresponding
NPC group. As in hearts from the young group, a sig-
nificant reduction in aortic flow, cardiac output and
Total Work occurred during reperfusion of NPC and PC
control and DIO middle-aged hearts.
In contrast to the young age matched control group,
ischaemic preconditioning did not improve functional
performance during reperfusion in both middle-aged
age-matched control and DIO groups. In fact, in both
control and DIO groups, function deteriorated, although
not significantly, as evidenced by the reduction in per-
centage recovery in Total Work (controls NPC: 42.4 ±
9.2; PC 28.4 ± 12.1; DIO NPC 41.8 ± 6.6; PC 21.6 ± 7.9).
The preconditioning-induced decline in function during
reperfusion, was also seen in the reduction in the num-
ber of hearts producing aortic output (Controls: NPC 7/
8 vs PC 2/6; DIO: NPC 8/9 vs PC 1/6).
Table 4 Effect of ischaemic preconditioning on functional recovery during reperfusion after 35 min regional ischaemia in young
(22 weeks) rats
Coronary flow
(ml/min)
Aortic flow
(ml/min)
Cardiac output
(ml/min)
Heart rate
(beats/min)
PSP
(mm Hg)
Total Work
(mW)
Total work
(% recovery)
Age-matched controls
Non-preconditioned (6)
a3/6 Before 18.3 ± 0.6 39.7 ± 3.5 57.7 ± 3.8 259 ± 6 92 ± 2 11.86 ± 1.01
After 6.9 ± 3.1 8.7 ± 4.1 15.6 ± 7.1 127 ± 57 42. ± 19 2.64 ± 1.23 19.7 ± 9.4
p 0.0051 0.0002 0.0004 0.0422 0.0226 0.0002
Preconditioned (5)
a5/5 Before 20.8 ± 0.8 37.2 ± 1.2 58 ± 1.8 261 ± 22 91 ± 3 12.2 ± 0.64
After 15.2 ± 0.8 23.2 ± 2.3 38.4 ± 3.0 243 ± 17 83 ± 2 7.49 ± 0.86 60.8 ± 4.5
p 0.0046 0.0008 0.0009 NS 0.0072 0.0004
p1 0.0441 0.0166 0.0226 NS NS 0.0124 0.0051
DIO
Non-preconditioned (6)
a6/6 Before 17.3 ± 0.7 33.7 ± 0.5 51.0 ± 10.9 243 ± 8 92 ± 1 10.48 ± 0.32
After 10.4 ± 1 9.2 ± 1.6 19.5 ± 1.7 246 ± 9 84 ± 1.9 3.67 ± 0.38 34.8 ± 2.99
p 0.0002 0.0001 0.0001 NS 0.0134 0.0001
Preconditioned (5)
a4/5 Before 20.8 ± 1.5 37.6 ± 3.0 58.4 ± 3.7 255 ± 6 94 ± 4 12.3 ± 0.89
After 15.2 ± 4.0 20.0 ± 5.2 35.2 ± 8.9 211 ± 53 71 ± 18 7.07 ± 1.78 54 ± 13
p NS NS 0.0056 NS NS 0.0091
p2 NS NS NS NS NS NS NS
p values indicate significance of difference between “after” and “before” values in each group
p1 values indicate significance of difference between “after” function of non-preconditioned and preconditioned hearts from age-matched control rats
p2 values indicate significance of difference between “after” function of non-preconditioned and preconditioned hearts from DIO rats
Numbers in brackets indicate number of rats
a Indicate number of hearts able to produce aortic output during reperfusion
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Echocardiography of DIO and age-matched control rats at
17 months
Echocardiographic evaluation was done in the 17 month
age-matched control and DIO groups only (Table 6).
Evaluation of the young rats has been previously done (see
ref 38). The left ventricle internal diameter at diastole
(LVIDd) and end diastolic left ventricular volume (EDV)
were significantly increased in the middle-aged DIO rats.
All other parameters were similar in the two groups.
Discussion
The hyperphagia-induced model of obesity, as originally
described by Pickavance and coworkers [34], was used in
Table 5 Effect of ischaemic preconditioning on functional recovery during reperfusion after 35 min regional ischaemia in
middle-aged (17 months) rats
Coronary flow
(ml/min)
Aortic flow
(ml/min)
Cardiac output
(ml/min)
Heart rate
(beats/min)
PSP
(mm Hg)
Total Work
(mW)
Total work
(% recovery)
Age-matched controls
Non-preconditioned (8)
a7/8 Before 20.5 ± 1.5 45.0 ± 1.4 65.5 ± 2.0 235 ± 11 104 ± 1 15.02 ± 0.5
After 22.1 ± 2.4 13.6 ± 4.9 35.8 ± 6.3 236 ± 37 77 ± 11 6.58 ± 1.58 42.4 ± 9.2
p NS 0.0001 0.0005 NS 0.0409 0.0003
Preconditioned (6)
a2/6 Before 18.5 ± 2.9 26.8 ± 5.5 45.3 ± 7.3 216 ± 27 104 ± 7 10.29 ± 1.62
After 12.0 ± 5.6 6.0 ± 4.1 18.0 ± 8.8 164 ± 56 51 ± 17 3.38 ± 1.78 28.4 ± 12.1
P NS 0.0123 0.0372 NS 0.0163 0.0168
p1 NS NS NS NS NS NS NS
DIO
Non-preconditioned (9)
a8/9 Before 19.0 ± 2.1 37.6 ± 3.4 56.6 ± 4 253 ± 17 100 ± 3 12.62 ± 1.12
After 22.3 ± 2.6 7.2 ± 1.8 29.6 ± 3.2 211 ± 34 77 ± 10 5.24 ± 0.86 41.8 ± 6.6
p NS 0.0001 0.0003 NS 0.0375 0.0005
Preconditioned (6)
a1/6 Before 17.8 ± 1.64 26.2 ± 5.6 44.0 ± 6.6 232 ± 32 108 ± 9 10.43 ± 1.8
After 15.0 ± 4.8 0 15.0 ± 4.8 164 ± 53 45 ± 15 1.81 ± 0.26 21.6 ± 7.9
p NS 0.0009 0.0056 NS 0.0065 0.0011
p2 NS 0.0078 0.0218 NS NS 0.0114 NS
p values indicate significance of difference between “after” and “before” values in each group
p1 values indicate significance of difference between “after” function of non-preconditioned and preconditioned hearts from age-matched control rats
p2 values indicate significance of difference between “after” function of non-preconditioned and preconditioned hearts from DIO rats
a Indicates number of hearts producing aortic output during reperfusion
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Fig. 2 Effect of ischaemic preconditioning on infarct size (% of
area at risk). Young (22 weeks) rats. n = 6–8/group. Abbreviations:
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risk). Middle-aged (M-A) (17 months) rats. n = 6–8/group. Abbreviations:
See Fig. 2
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this study. This diet resulted in an initial significant rise
in body weight and intraperitoneal fat seen after
16 weeks on the diet. This difference was still present
after 17 months, although aging per se also caused a sig-
nificant increase in intraperitoneal fat in the age-
matched controls. We have previously demonstrated
that the diet induced insulin resistance associated with a
significant rise in serum insulin but not glucose levels
[38].
A number of interesting observations were made using
the well-characterized isolated working perfused rat
heart for evaluation of necrosis and function: (i) expos-
ure of hearts of young rats to 35 min of regional ischae-
mia resulted in a significant reduction in infarct size in
DIO hearts compared to their AMC (Fig. 1), confirming
previous observations made in the same model [22, 23].
With increasing the age to 17 months, however, the dif-
ference between AMC and DIO hearts was no longer
observed (ii) baseline functional performance of the
working heart model, was similar in hearts from AMC
and DIO rats and not affected by age (iii) contrary to
expectations, after regional ischaemia hearts from
middle-aged AMC rats recovered functionally during
reperfusion as well as their younger (22 weeks) coun-
terparts (iv) the reduction in infarct size of DIO hearts
after 22 weeks, was not associated with an improve-
ment in functional recovery, probably due to concomi-
tant stunning (v) infarct size as well as functional
recovery during reperfusion of hearts from DIO rats
were not affected by age and no differences were ob-
served in these parameters after 17 months when com-
pared with those after 22 weeks (vi) although hearts
from middle-aged AMC and DIO rats can be precondi-
tioned, functional recovery was depressed in both
middle-aged groups despite the very significant reduc-
tion in infarct size (Fig. 3).
Effect of age: It is clear from the above summary, that
the results obtained in the present study differ from the
generally accepted viewpoint, namely that aging has
detrimental effects on the mechanical performance of
the heart as well as on its response to I/R injury. The
aging cardiomyocyte has been described to develop a
reduction in tolerance to stress, mitochondrial function
and contractile function associated with increased sus-
ceptibility to apoptosis and necrosis (for review see
[39]) with ROS playing a pivotal role. Interestingly,
many of the studies on the aging myocardium have
been done on mouse hearts, with mice aged 12 months
being regarded as “middle-aged” and those aged 24–28
months as “aged” [11]. Since rats aged 24 months have
been regarded as old [1, 2], the rats used in the present
study (aged 17 months), were regarded as “middle-
aged” rather than aged and could account for the fact
that no marked differences in baseline mechanical per-
formance and in the response to regional ischaemia
were seen in the present study, regardless of age. How-
ever, no significant increase in infarct size between
young and aging cohorts has also been reported by two
other groups namely Schulman [31] and Fenton and
coworkers [40]. Interestingly, in both the latter studies
rats aged 18–20 months [31] and 22 months [40] were
regarded as “aged”.
It should be kept in mind that the mechanical per-
formance of the working heart model was evaluated
under carefully controlled baseline conditions, such as
fixed pre-and afterloads, without pacing. Their response
to increased workloads, which may disclose defects in
performance, was not investigated in the present study
and is a topic for further experiments. It should be noted
that exposure to more severe ischaemic stress, namely15
min global ischaemia, indicated that hearts from middle-
aged DIO rats are more susceptible to ischaemic damage
than their age-matched controls (Table 3).
Effect of obesity: Since obesity-induced insulin resist-
ance as well I/R are known to be associated with increased
oxidative stress [14–16], it was expected that the combin-
ation of age and obesity should exacerbate myocardial I/R
injury. However, indications are that the model of
hyperphagia-induced obesity used in the present study, is
not characterized by significant oxidative stress: normal-
ized values for serum TBARS, conjugated dienes and lipid
hydroperoxide were similar to those of age-matched con-
trols [20], suggesting that this phenomenon may not play
a role in the results obtained.
Table 6 Echocardiography data of middle-aged control and DIO rats
Control (4) DIO (4) p
ESV (End systolic LV volume, ml 0.15 ± 0.02 0.17 ± 0.02 NS
FS (Fractional shortening, %) 45.04 ± 1.84 49.22 ± 1.56 NS
IVSs (Intraventricular septum thickness In systole, cm) 0.34 ± 0.01 0.32 ± 0.01 NS
LVPWd (LV posterior wall thickness at diastole, cm) 0.25 ± 0.01 0.23 ± 0.01 NS
LVIDd (LV internal diameter at diastole, cm) 0.70 ± 0.02 0.79 ± 0.02 <0.003
EDV (end-diastolic LV volume, ml) 0.78 ± 0.05 1.08 ± 0.07 <0.003
IVSd (Intraventricular septum thickness at diastole, cm 0.19 ± 0.01 0.19 ± 0.01 NS
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Thus in the working heart model subjected to re-
gional ischaemia, functional recovery during reperfu-
sion of DIO hearts did not differ significantly between
the young and middle-aged groups, although there are
indications of deterioration in the hearts of the latter
groups when subjected to global ischaemia (Table 3).
This possibility is supported by the echocardiographic
studies done in the middle- aged group which indicated
a significant increase in LVIDd and EDV (Table 6).
Dilated left ventricles with preserved systolic function
are indicative of early stage dilated cardiomyopathy
[41]. Whether this was the case in the DIO hearts re-
mains to be determined. Interestingly, a similar increase
in LVIDd was seen in young (16–20 week) DIO rats
[42]. Obesity however had no significant effect on frac-
tional shortening. Using a similar model of obesity,
Wensley and coworkers could not find any echocardio-
graphic changes after 32 weeks on the diet [18].
The reduction in infarct size observed in young DIO
rats as well as the fact that all these hearts subjected to
I/R were able to produce aortic output during reperfu-
sion suggest that the diet protect against I/R damage,
confirming previous data from our laboratory [23].
These observations are also in agreement with the find-
ings in a similar model [22] and in fructose-fed rats [43].
However, our results are in contrast with those obtained
in genetic deletion models of obesity [44–46] and in diet
models [24, 47–49] where infarct size was either in-
creased or unchanged respectively. The reasons for these
controversies are not clear yet but may be due to,
amongst other factors, differences in experimental pro-
tocols, diet, age and species of the animals etc. In our
own hands, preference was given to use of infarct size as
the more robust endpoint instead of left ventricular
function which can be influenced by other factors such
as concomitant stunning during reperfusion.
Explanations for the beneficial effects observed of
obesity and insulin resistance on the outcome of I/R
remain to be established. A previous study from our la-
boratory on 22 week old DIO rats did not show an
association between the reduction in infarct size and
activation of the RISK pathway during reperfusion [23],
a signalling pathway which has been shown to be acti-
vated during cardioprotection in many experimental in-
terventions [50, 51]. As far as we know, the role of the
JAK-STAT pathway has not been investigated in this
regard.
Possible signalling mechanisms involved in the effects
of obese-insulin resistance have been reviewed by Apaijai
and coworkers [4]. Unfortunately, as was the case in the
outcome of the effects of I/R, no clear-cut pattern of
changes emerged. Another factor which could contribute
to the many discrepancies observed, is the fact that the
time of sampling for Western blotting varied from
30 min [52] to 10 min of reperfusion [23] or before in-
duction of ischaemia [18, 22]. Clearly further studies are
required.
Preconditioning: Cardioprotection in old age and
obesity has become a very relevant clinical problem in
view of the fact that the developed countries are faced
with an increasing elderly population. With regard to
cardioprotection in the aging heart, a number of com-
prehensive reviews recently appeared [1–4] which indi-
cated a loss in the ability to be preconditioned in the
aging heart [27, 40, 53, 54]. For example, using infarct
size as endpoint, Schulman and coworkers [31] showed
that hearts from rats aged 18–20 months, could not be
preconditioned by either multiple episodes of I/R or
pharmacologically while the blunted response in middle-
aged rat hearts could be improved by an increased pre-
conditioning stimulus. Effective preconditioning in other
aging species such as the rabbit [55] has been reported,
although this was attributed to the possibility that the
animals used in these two studies were probably not old
enough to qualify as “old”, taking their lifespan into ac-
count [47]. Another explanation for these discrepancies
is the fact that many of the previous studies used iso-
lated hearts relying on functional recovery as endpoint
[27, 28], which, in contrast to infarct size reduction, is
regarded as less reliable.
Although type 2 diabetes has been associated with im-
paired PI3kinase/Akt signalling, GLUT4 expression as
well as defects in AMPK and other kinases involved in
preconditioning [56], our study showed that hearts from
young DIO (insulin- resistant, but not diabetic) rats ap-
pear to be preconditioned already, while hearts from
middle-aged DIO rats showed a significant reduction in
infarct size when preconditioned (Figs. 2 and 3). Clearly
the possibility that obesity may have beneficial effects on
the myocardial response to I/R injury in young animals
needs to be further investigated.
The very significant reduction in infarct size induced
by ischaemic preconditioning in hearts from both
middle-aged control and DIO rats (Fig. 3), was associ-
ated with a marked lowering in the ability to recover
functionally during reperfusion as indicated by the over-
all reduction in % recovery in Total Work performed
(see Table 5), when compared to their NPC counter-
parts. A lack of association between infarct size reduc-
tion and improved functional recovery has been
observed by several groups [57–59] and attributed to
concomitant stunning. It is generally accepted that myo-
cardial stunning is due to the formation of reactive oxy-
gen species and cytosolic calcium overloading during
reperfusion (for review see [60]). Using cardiomyocytes
isolated from hearts of young and aged rats, O’Brien and
coworkers [53] demonstrated that although the degree
of contractile depression was comparable in both age
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groups, the aged cardiomyocytes exhibited a much
greater and more prolonged accumulation of diastolic
calcium in ischaemia. Increased cytosolic calcium as well
as increased oxidative stress during early reperfusion,
particularly in hearts from DIO rats, may cause severe
stunning in the aged hearts. In fact, it has been shown
that postischaemic stunning may be exacerbated in the
senescent rat heart [61]. However, despite these possibil-
ities, functional recovery by hearts from AMC and DIO
rats albeit depressed, did not differ significantly and it is
only when preconditioned, that hearts from middle-aged
rats showed such a marked inability to recover function.
A possible explanation could be that the additional gen-
eration of ROS during the preconditioning protocol
could cause the severe mechanical dysfunction in the
older animals. However, in view of the many complex-
ities of ischaemic preconditioning this phenomenon
should be further investigated. In a study of potential
molecular mechanisms, Griecsova and coworkers [54]
demonstrated that loss of preconditioning protection
was associated with age-dependent reduced Akt/PKB
phosphorylation and eNOS and PKCepsilon levels in
hearts of mature rats compared with the younger ones,
as well as a failure of preconditioning to upregulate
these proteins, confirming data obtained in an earlier
study by Iemitsu et al. [62]. The involvement of the RISK
pathway, particularly in the middle-aged AMC and DIO
rats, in the myocardial response to I/R injury, should be
further investigated, with a specific focus on the time of
sampling.
Conclusions
The data obtained in this study showed that, contrary to
expectations, middle-age as well as obesity per se did
not affect myocardial function at baseline level and did
not increase the susceptibility of the heart to I/R dam-
age, as indicated by infarct size and functional recovery
during reperfusion after regional ischaemia. In fact,
obesity appears to be beneficial in young animals as indi-
cated by the reduction in infarct size when compared to
their age-matched controls. These results are in contrast
with the many well-established age-related modifications
in the cardiovascular system [1–3], but it should be kept
in mind that our observations were made in healthy ani-
mals, without the comorbidities which may affect the
outcome. There is also continued interest in the ability
of cardioprotective interventions such as pre-or postcon-
ditioning to protect the ageing myocardium [1–4]. Our
data showed that although aging hearts exhibited normal
function under baseline conditions, with an unchanged
response to I/R and retention of the capacity to reduce
infarct size when preconditioned, this was associated
with a reduction in the ability to recover functionality.
This is an important observation in view of the
increasingly aging population in some countries where a
loss of endogenous protection could have serious conse-
quences for old patients. It is clear that further work is
required to elucidate the effects of age and obesity on
the outcome of cardioprotective interventions, with par-
ticular attention to the molecular mechanisms involved.
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